Where does Biontech Ag rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Biontech Ag ranks #9,720 of 50,000 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Biontech Ag hold?

Biontech Ag holds 32 US utility patents granted between 2015 and 2023, spanning 11 technology areas.

What is Biontech Ag's Innovation Score?

Biontech Ag has an Innovation Score of 31.1 out of 100 (top 64% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Biontech Ag's patent grant rate increasing or decreasing?

Biontech Ag's recent grant velocity is -77% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Biontech Ag's patents?

Biontech Ag's patents average 11.0 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Biontech Ag patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Biontech Ag

Q: What technology areas does Biontech Ag focus on?

Biontech Ag's top technology area is A61P (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS) with 25 patents. Grants appear in 11 CPC subclasses total.

USPTO PatentsView assignee record - 32 granted patents across 11 technology areas, recorded in grant years 2015–2023. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS).

Compiled by PlainPatent · May 15, 2026

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Biontech ranks #9,720 of 50,000 tracked US assignees by granted-patent volume, with 32 patents across 11 technology areas.

#9,720
of 50,000 US assignees by volume: Top 64%
by Innovation Score (31.1/100): 11.0
avg claims per patent: -77%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R9720 · Foreign Corporation #9,720 · 32 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-PAR · TYPE-FRNCORP · VEL-DROP · BOOK-FULL

GRANTS-SMALL 32 grants
UPPER-Q #9,720/50,000
PHOTO-FINISH Beijing Pico Technol…
CPC-FOCUS A61P · 11 areas
INNOV-THIN 31.1/100
CLAIMS-PAR 11.0 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-DROP -77% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Beijing Pico Technology Co., Ltd. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Bioz · near

31
Hexmodal · near

31
Biontech · this assignee

31
Sorenson Media · near

31
Fuerst Group · near

31
3D Lighting Innovati… · lowest

7

What this shows Biontech Ag stamps GRANTS-SMALL, UPPER-Q, PHOTO-FINISH, CPC-FOCUS, INNOV-THIN, CLAIMS-PAR, TYPE-FRNCORP, VEL-DROP, BOOK-FULL. Volume places it #9,720 of 50,000; Innovation Score 31.1/100 sits in the top 64% of the PatentsView-derived corpus. Closest grant-volume peer on this plate is Beijing Pico Technology Co., Ltd. (±0 grants).

Portfolio overview

Biontech Ag has been granted 32 US utility patents between 2015 and 2023, placing Biontech Ag at #9,720 of 50,000 across all assignees tracked by PlainPatent. This portfolio spans 11 distinct Cooperative Patent Classification (CPC) subclasses, averaging 11.0 claims per patent with primary concentration in A61P (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS). As a Foreign Corporation, Biontech Ag is one of the more focused assignees in the PatentsView dataset. By volume, Biontech sits between BTL Healthcare Technologies A.s. (32 patents, rank #9,721) and CEM Corporation (32 patents, rank #9,729) - the closest US assignees by grant volume. The composite Innovation Score of 31.1/100 blends portfolio volume, grant velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Grant cadence records the difference between two grant-year windows. Between 2020 and 2024 the company received 6 grants, compared with 26 in the 2015–2019 window, a -77% shift in five-year grant velocity. Both windows cover five complete grant years; the latest PatentsView year is a partial release and is excluded from this comparison, though it still appears in the yearly table and chart below. Grant timing can lag the related application by years, so this comparison does not establish current R&D spending, strategic intent, or a company’s application activity. The Foreign Corporation classification provides context for the assignee record, not a conclusion about its business strategy.

Claim depth and technology breadth describe this aggregate record. Biontech Ag's 11.0 average claims per patent is an average count, not a measure of claim scope, legal strength, enforceability, or design-around risk. The record spans 11 CPC subclasses. Combined with portfolio volume, these figures let readers compare the documented grant records of assignees in similar technology classes.

BTL Healthcare A S

32
Beijing Pico Tech…

32
Beijing Tusen Wei…

32
Bently Nevada

32
Biofire Defense

32
Board of Supervis…

32
CBF Networks

32
CEM

32
Biontech ◀

32

What this shows Biontech holds 32 patents at rank #9,725, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Biontech

By rank, the assignees closest to #9,725 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in Biontech's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Biontech, neither rank-band nor same-CPC leaders (those blocks stay above).

Similar innovation score

Nearest assignees by Innovation Score (31 here).

Sorenson Media, Inc. 31 Bioz, Inc. 31 Hexmodal Technologies Llc 31 Fuerst Group, Inc. 31

Biontech's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

31 Top 64% higher than 36% of 50,000 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2023

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Biontech Ag patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	7	21.9%
2016	5	15.6%
2017	5	15.6%
2018	4	12.5%
2019	5	15.6%
2020	4	12.5%
2021	1	3.1%
2023	1	3.1%

Which technologies does Biontech Ag patent most?

A61P - SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 25

A61K - PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES 24

C07K - PEPTIDES 22

C12Q - MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS ; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES 11

G01N - INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 11

C12N - MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA 7

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY 2

C07D - HETEROCYCLIC COMPOUNDS 2

B82Y - SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES 2

G16B - BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY 2

C12Y - ENZYMES 1

Top 11 of 11 technology areas

Where it ranks

Overall rank by patents

#9,720

of 50,000 tracked assignees

Innovation Score

31.1 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.